Suppr超能文献

1967年至2024年香港实现并维持消除麻疹:可吸取的经验教训

Achieving and sustaining measles elimination in Hong Kong, from 1967 to 2024: lessons to be learnt.

作者信息

Chan Jeffery Ching Ho, Rosa Duque Jaime S, Durrheim David N, Tsang Thomas, Lau Yu Lung

机构信息

Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong.

Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong

出版信息

BMJ Glob Health. 2025 Jun 30;10(6):e018973. doi: 10.1136/bmjgh-2025-018973.

Abstract

Following the development and roll-out of the measles vaccine in 1954, measles incidence dropped to low levels in areas where measles vaccines with high coverage were introduced. The Measles and Rubella Strategic Framework 2021-2030 developed by the Measles & Rubella Initiative aims to eliminate measles globally by 2030. However, there has been a resurgence of measles cases after the COVID-19 pandemic in many countries, including some in the Western Pacific Region. This review describes the journey from 1967, when Hong Kong introduced a single-dose regimen, to 2024 when Hong Kong had been experiencing an increase in imported measles cases despite being verified to have achieved measles elimination in 2016. Hong Kong's experience in maintaining high vaccination coverage and comprehensive surveillance may provide an exemplary framework for other countries in the Western Pacific Region.

摘要

1954年麻疹疫苗研发并推广后,在引入高覆盖率麻疹疫苗的地区,麻疹发病率降至低水平。麻疹和风疹倡议组织制定的《2021-2030年麻疹和风疹战略框架》旨在到2030年在全球消除麻疹。然而,在包括西太平洋区域一些国家在内的许多国家,新冠疫情后麻疹病例有所反弹。本综述描述了从1967年香港引入单剂次接种方案,到2024年香港尽管在2016年已被证实实现麻疹消除,但仍出现输入性麻疹病例增加的历程。香港在维持高疫苗接种覆盖率和全面监测方面的经验可能为西太平洋区域其他国家提供一个典范框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba11/12211821/a0c2b99008ac/bmjgh-10-6-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验